Free Trial
ETR:CCAP

CORESTATE Capital (CCAP) Stock Price, News & Analysis

CORESTATE Capital logo
€0.27 0.00 (0.00%)
As of 08/8/2025

About CORESTATE Capital Stock (ETR:CCAP)

Key Stats

Today's Range
€0.27
€0.27
50-Day Range
€0.24
€0.31
52-Week Range
€0.26
€0.76
Volume
818 shs
Average Volume
N/A
Market Capitalization
€45.44 million
P/E Ratio
N/A
Dividend Yield
912.41%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

CCAP Stock News Headlines

Corestate Capital Holding S.A.
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.
Corestate Capital Holding SA
Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)
See More Headlines

CCAP Stock Analysis - Frequently Asked Questions

CORESTATE Capital's stock was trading at €0.36 on January 1st, 2025. Since then, CCAP stock has decreased by 23.9% and is now trading at €0.27.

Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), ARAVIVE (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Real Estate Services
Sub-Industry
Financial Services
Current Symbol
ETR:CCAP
CIK
N/A
Fax
N/A
Employees
446
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
(€21.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.01
Net Income
-€3.50 billion
Net Margins
-1,143.36%
Pretax Margin
N/A
Return on Equity
-269.30%
Return on Assets
-7.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
0.17

Sales & Book Value

Annual Sales
€306.04 million
Price / Sales
0.15
Cash Flow
€0.46 per share
Price / Cash Flow
0.60
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
165,831,023
Free Float
N/A
Market Cap
€45.44 million
Optionable
Not Optionable
Beta
1.03
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (ETR:CCAP) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners